Leaders and physicians from FCS will participate in the 2023 FLASCO Fall Session

Fort Myers, Fla., October 19, 2023 – Florida Cancer Specialists & Research Institute, LLC (FCS) clinicians and senior leaders are among the industry experts who will present breakthrough data, research and clinical strategies at the Florida Society of Clinical Oncology (FLASCO) Fall Session in Orlando this month. The gathering of oncology medical professionals and multidisciplinary teams that manage healthcare for cancer patients across the state will feature dynamic educational tracks that address current and future changes in the landscape of cancer care.

Serving as panelists are:

• Colleen Lewis, MSN, AN-BC, AOCNP, FCS Vice President of Nursing & Research – Leadership & Your Potential: APP Professional and Personal Growth & Development Featuring APP Leader Insights From Across Florida (APP Track)
• Karen Ridley, MSW, LCSW, FCS Behavioral Health Manager, Navigating a Cancer Diagnosis Best Practices in Oncology Distress Management: Beyond the Screening (Nurse Navigator Track)

Presenters from FCS include:

• Kristen Boykin, PharmD, BCOP, BCPS, FCS Director of Pharmacy Operations and Pharmacist Liaison to the FLASCO Board of Directors – Oncology Drug Shortages: Learnings from Recent Incidents and Coping Strategies
• Roger Orr, PharmD, BCOP, FCS Associate Director of Pharmacy Clinical Services, and Jeanine Ewing, PharmD, BCOP, FCS Clinical Oncology Pharmacist – Updates in Therapy (Pharmacy Track)
• Natasha Khrystolubova, RPH, BPharm, BCOP, FCS Director of Pharmacy Clinical Services and Pharmacist Liaison to the FLASCO Board of Directors – Medically Integrated Pharmacy Model; Challenges, Opportunities and Role of the Pharmacist in Oral Oncolytic Management (Pharmacy Track)
• Wendy Migliore-Sanchez, APRN, AOCNP-BC, AGACNP-BC, FCS Advanced Practice Registered Nurse – Mitigating Adverse Events: Bispecifics (APP Track)

FCS President & Managing Physician Lucio N. Gordan, MD, noted, “This FLASCO session provides a premier opportunity for us to network with our statewide colleagues, share best practices to improve clinical outcomes and find solutions to the ever-present challenges we face on a daily basis.”

“Through our long-standing history of leadership involvement in FLASCO, we continue to enhance the overall experience for cancer patients across Florida and ensure access to the highest-quality care, close to home,” said FCS Chief Executive Officer Nathan H. Walcker.

The following FCS medical oncologists currently serve in leadership roles on the FLASCO Board of Directors:

• Maen Hussein, MD – Vice President
• Faithlore Gardner, MD – Secretary
• Barry Berman, MD, MS – Finance Committee Chair
• Paresh Patel, MD – Legislative Committee Chair
• Richard McDonough, MD – Past President and Nominating Committee Chair
• Scott Tetreault, MD, Legislative Vice Chairman (State)
• Jennifer Cultrera, MD – Fellow/Resident Program Outreach Program Co-Chair

Also serving on the FLASCO Board of Directors are FCS medical oncologists Eric Harris, DO, Nalini Hasija, MD, Cesar Augusto Perez, MD and Magali Van den Bergh, MD. Additionally, FCS Vice President of Marketing Michelle Robey, serves as Marketing Liaison to the FLASCO Board.

The Florida Society of Clinical Oncology (FLASCO) is a member-supported statewide non-profit organization committed to facilitating and promoting multidisciplinary efforts for oncology practitioners and industry professionals to improve patient care in Florida.